Literature DB >> 32448621

High overall confidence in childhood vaccination in Norway, slightly lower among the unemployed and those with a lower level of education.

Anneke Steens1, Pawel Stefanoff2, Anita Daae2, Didrik F Vestrheim2, Marianne A Riise Bergsaker2.   

Abstract

In Norway, childhood immunisation is offered on voluntary basis, free of charge and is delivered through trained nurses at > 650 child health centres and school health services. Maintaining high confidence in the vaccination programme is key to sustaining high vaccine uptake. We aimed to investigate confidence in childhood vaccination in the general population and to identify determinants for lower confidence. In 2017 and 2018, Statistics Norway asked questions on confidence in childhood vaccination (to all respondents) and children's vaccination history (to parents) in their routine cross-sectional survey. Respondents reported their level of agreement on a five-point Likert scale. Using a weighted analysis we calculated proportions agreeing [95% confidence interval] by respondent characteristics. Overall, 2169 individuals participated (54% response). 95.8% [94.8-96.7] answered that vaccination is important, 93.4% [92.2-94.4] thought that vaccines are safe, 96.0% [95.0-96.8] thought that vaccines are effective and for 93.4% [92.2-94.4] vaccination was compatible with their basic values. Those with lower level of education expressed lower confidence in vaccination due to conflict with their basic values (88.2% [84.7-91.0] answered positively). Those unemployed expressed lower confidence due to conflict with their basic values (81.9% [71.8-88.9]) and because of concerns about vaccines' safety (83.5% [73.7-90.1]). 96.3% [94.3-97.6] of parents (n = 580) had their children fully vaccinated, despite that one fifth answered that they at least once have had doubts on whether or not to vaccinate their children. There is high confidence in childhood vaccination in Norway. Those with a lower level of education and the unemployed reported comparatively lower confidence. To maintain high confidence in childhood vaccination, we recommend maintaining the well-informed system with easily accessible vaccinations. Furthermore, we recommend maintaining surveillance of vaccine confidence, supplemented with targeted studies on subgroups who are less confident, express doubts and/or oppose vaccination. Those studies should inform communication strategies tailored to subgroups.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32448621     DOI: 10.1016/j.vaccine.2020.05.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.

Authors:  Giovanna Elisa Calabro'; Elettra Carini; Alessia Tognetto; Irene Giacchetta; Ester Bonanno; Marco Mariani; Walter Ricciardi; Chiara de Waure
Journal:  Front Public Health       Date:  2022-03-09

2.  Right-wing ideological constraint and vaccine refusal: The case of the COVID-19 vaccine in Norway.

Authors:  Dag Wollebæk; Audun Fladmoe; Kari Steen-Johnsen; Øyvind Ihlen
Journal:  Scan Polit Stud       Date:  2022-03-14

3.  Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children.

Authors:  Krista Salo-Tuominen; Tamara Teros-Jaakkola; Laura Toivonen; Helena Ollila; Päivi Rautava; Minna Aromaa; Elina Lahti; Niina Junttila; Ville Peltola
Journal:  Vaccine       Date:  2022-05-17       Impact factor: 4.169

4.  Vaccination conspiracy beliefs among social science & humanities and STEM educated people-An analysis of the mediation paths.

Authors:  Željko Pavić; Adrijana Šuljok
Journal:  PLoS One       Date:  2022-03-01       Impact factor: 3.240

5.  Influenza risk groups in Norway by education and employment status.

Authors:  Birgitte Klüwer; Kjersti Margrethe Rydland; Ida Laake; Megan Todd; Lene Kristine Juvet; Svenn-Erik Mamelund
Journal:  Scand J Public Health       Date:  2021-12-20       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.